Heterogeneity in breast cancer:
Current evidence and clinical practice

Breast cancer is intrinsically heterogeneous, a feature that confers complexity and adds to the challenges faced by clinicians diagnosing and managing the disease. Through a series of educational resources, supported by GE HealthCare and delivered by a distinguished faculty, learn how this characteristic influences disease progression, recurrence, therapeutic resistance, and prognosis.

Support for the development of this content has been provided by GE HealthCare, Medical Affairs